ACTH-producing medullary thyroid cancer. Clinical case.
https://doi.org/10.14341/probl201662445-49
Abstract
Medullary thyroid cancer with ectopic ACTH production - the disease is extremely rare. The literature describes only a few cases of this disease. Rare ectopic ACTH syndrome caused by medullary thyroid cancer, and the diversity of the clinical picture are responsible for numerous diagnostic errors leading to ineffective treatment. In this regard, we consider it expedient to share our own experience in this area.
About the Authors
Evgenia I. MarovaRussian Federation
MD, PhD
Competing Interests:
No conflict of interest
Ludmila Ya. Rozhinskaya
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Iya A. Voronkova
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Oleg V. Remizov
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Anna I. Zavalishina
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Konstantin Yu. Slashchuk
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Mihail I. Davydov
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Vitaliy Zh. Brzhezovsky
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Sergey A. Gerasimov
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Antonio K. Chekini
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Dmitry K. Stelmach
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Maksim B. Pak
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
References
1. Ball DW. American thyroid association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective. Thyroid. 2009;19(6):547-550. doi: 10.1089/thy.2009.0147
2. Alexandraki KI, Grossman AB. The ectopic ACTH syndrome. Reviews. Endocrine and Metabolic Disorders. 2010;11(2):117-126. doi: 10.1007/s11154-010-9139-z
3. Chrisoulidou A, Pazaitou-Panayiotou K, Georgiou E, et al. Ectopic Cushing’s syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma. Hormones (Athens). 2008;7(3):259-262.
4. Sheikh-Ali M, Krishna M, Lloyd R, Smallridge RC. Predicting the development of Cushing’s syndrome in medullary thyroid cancer: utility of proopiomelanocortin messenger ribonucleic acid in situ hybridization. Thyroid. 2007;17(7):631-634. doi: 10.1089/thy.2007.0062
5. Tyer NM, Braunstein GD, Frishberg D. Unusual case of multiple endocrine neoplasia type 2a syndrome without medullary thyroid carcinoma. Endocr Pract. 2011;17(2):E4-E7. doi: 10.4158/ep10157.CR
6. Samir Saini NB. Tale of two endocrine organs: medullary thyroid carcinoma (MTC) with ectopic Cushing syndrome. Surgery: Current Research. 2014;05(01). doi: 10.4172/2161-1076.1000217
7. Willhauck MJ, Popperl G, Rachinger W, et al. An unusual case of ectopic acth syndrome. Exp Clin Endocrinol Diabetes. 2012;120(2):63-67. doi: 10.1055/s-0031-1297967
8. Sand M, Uecker S, Bechara FG, et al. Simultaneous ectopic adrenocorticotropic hormone syndrome and adrenal metastasis of a medullary thyroid carcinoma causing paraneoplastic Cushing’s syndrome. Int Semin Surg Oncol. 2007;4:15. doi: 10.1186/1477-7800-4-15
9. Farage M, Costa MA, Godoy-Matos AF. A rare case of Cushing syndrome by cyclic ectopic-ACTH. Arq Bras Endocrinol Metabol. 2012;56(5):324-330.
10. Barroso-Sousa R, Lerario AM, Evangelista J, et al. Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome. Thyroid. 2014;24(6):1062-1066. doi: 10.1089/thy.2013.0571
11. Barbosa SL, Rodien P, Leboulleux S, et al. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid. 2005;15(6):618-623. doi: 10.1089/thy.2005.15.618
12. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, et al. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011;117(19):4381-4389. doi: 10.1002/cccr.26029
13. Singh K, Sharma Mc, Jain D, Kumar R. Melanotic medullary carcinoma of thyroid—report of a rare case with brief review of literature. Diagn Pathol. 2008;3:2. doi: 10.1186/1746-1596-3-2
14. Кузнецов Н.С., Латкина Н.В., Добрева Е.А. АКТГ-эктопированный синдром: клиника, диагностика, лечение. // Эндокринная хирургия. — 2012. — Т. 6. — №1 - C. 24-36. [Kuznetsov NS, Latkina NV, Dobreva EA. Еctopic ACTH syndrome: clinical picture, diagnosis, treatment. Endocrine Surgery. 2012;(1):24-36]. (In Russ.). doi: 10.14341/2306-3513-2012-1-24-36
15. Трошина Е.А., Бельцевич Д.Г., Молашенко Н.В., Газизова Д.О. Диагностика, дифференциальная диагностика и лечение эндогенного гиперкортицизма. // Проблемы эндокринологии. — 2010. — Т. 56. — №2. — C. 53-63. [Troshina EA, Bel’tsevich DG, Molashenko NV, Gazizova DO. Diagnosis, differential diagnosis, and treatment of endogenous hypercorticism. Probl Endokrinol (Mosk).2010;56(2):53-63]. (In Russ.). doi: 10.14341/probl201056253-63
16. Марова Е.И., Кокшагина Н.В., Рожинская Л.Я. АКЕГ-продуцирующие нейроэндокринные опухоли грудной клетки. // Проблемы эндокринологии. — 2010. — Т. 56. — №5. — C. 8-14. [Marova EI, Kokshagina NV, Rozhinskaia LI. ACTH-producing neuroendocrine chest wall tumours. Probl Endokrinol (Mosk). 2010;56(5):8-14]. (In Russ.). doi: 10.14341/probl20105658-14
17. Ходакова Ю.В., Ароапова С.Д., Суханова Г.А. и др. Нарушения в системе гемостаза при эндогенном гиперкортицизме и метаболическом синдроме. // Проблемы эндокринологии. — 2010. — Т. 56. — № 4. — C. 34-38. [Khodakova IV, Arapova SD, Sukhanova GA, et al. Disturbances in the hemostatic system of patients with endogenous hypercorticism and metabolic syndrome. Probl Endokrinol (Mosk). 2010;56(4):34-38]. (In Russ.). doi: 10.14341/probl201056434-38
18. Wells SAJr, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol. 2012;30(2):134-141. doi: 10.1200/JCO.2011.35.5040
19. Baudry C, Paepegaey AC, Groussin L. Reversal of Cushing’s syndrome by Vandetanib in medullary thyroid carcinoma. N Engl J Med. 2013;369(6):584-586. doi: 10.1056/nejmc1301428
20. Nella AA, et al. Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J Clin Endocrinol Metab. 2014;99(9):3055-3059. doi: 10.1210/jc.2013-4340
Supplementary files
Review
For citations:
Marova E.I., Rozhinskaya L.Ya., Voronkova I.A., Remizov O.V., Zavalishina A.I., Slashchuk K.Yu., Davydov M.I., Brzhezovsky V.Zh., Gerasimov S.A., Chekini A.K., Stelmach D.K., Pak M.B. ACTH-producing medullary thyroid cancer. Clinical case. Problems of Endocrinology. 2016;62(4):45-49. (In Russ.) https://doi.org/10.14341/probl201662445-49

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).